Novel Purification Process for Amyloid Beta Peptide(1-40)
暂无分享,去创建一个
[1] M. Brimble,et al. Efficient synthesis and characterisation of the amyloid beta peptide, Aβ1-42, using a double linker system. , 2018, Organic & biomolecular chemistry.
[2] E. Kobatake,et al. Fluorescent and luminescent fusion proteins for analyses of amyloid beta peptide aggregation , 2017, Journal of peptide science : an official publication of the European Peptide Society.
[3] M. Meldal,et al. C-Terminally modified peptides via cleavage of the HMBA linker by O-, N- or S-nucleophiles. , 2016, Organic & biomolecular chemistry.
[4] Tuomas P. J. Knowles,et al. The amyloid state and its association with protein misfolding diseases , 2014, Nature Reviews Molecular Cell Biology.
[5] I. Hamley. The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization. , 2012, Chemical reviews.
[6] M. Biancalana,et al. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. , 2010, Biochimica et biophysica acta.
[7] J. Kelly,et al. Site-specific modification of Alzheimer's peptides by cholesterol oxidation products enhances aggregation energetics and neurotoxicity , 2009, Proceedings of the National Academy of Sciences.
[8] B. Penke,et al. Synthesis of Aβ[1‐42] and its derivatives with improved efficiency , 2007, Journal of peptide science : an official publication of the European Peptide Society.
[9] R. Tanzi,et al. Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.
[10] Y. Kiso,et al. Novel and efficient synthesis of difficult sequence-containing peptides through O-N intramolecular acyl migration reaction of O-acyl isopeptides. , 2004, Chemical communications.
[11] A. Clippingdale,et al. Amyloid-β as a “Difficult Sequence” in Solid Phase Peptide Synthesis , 2004 .
[12] Y. Kiso,et al. Design and synthesis of a novel water-soluble Aβ1-42 isopeptide: an efficient strategy for the preparation of Alzheimer's disease-related peptide, Aβ1-42, via O–N intramolecular acyl migration reaction , 2004 .
[13] M. Skwarczynski,et al. ON intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence‐containing bioactive peptides , 2004, Biopolymers.
[14] A. Clippingdale,et al. Amyloid-beta as a "difficult sequence" in solid phase peptide synthesis. , 2004, Protein and peptide letters.
[15] M. Mutter,et al. Pseudo-prolines (ΨPro): direct insertion of ΨPro systems into cysteine containing peptides , 2002 .
[16] D. Walsh,et al. An improved method of preparing the amyloid β-protein for fibrillogenesis and neurotoxicity experiments , 2000, Neurobiology of Aging.
[17] W. Chan,et al. Fmoc solid phase peptide synthesis : a practical approach , 2000 .
[18] E. Giralt,et al. Reduction of methionine sulfoxide with NH4I TFA: Compatibility with peptides containing cysteine and aromatic amino acids , 1998 .
[19] Bruce A. Yankner,et al. Aging renders the brain vulnerable to amyloid β-protein neurotoxicity , 1998, Nature Medicine.
[20] J. Kelly,et al. Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.
[21] W. Turnell,et al. Improved preparation of β-amyloid(1–43): structural insight leading to optimised positioning of N-(2-hydroxy-4-methoxybenzyl)(Hmb) backbone amide protection , 1995 .
[22] R. Sheppard,et al. N,O‐bisFmoc derivatives of N‐(2‐hydroxy‐4‐methoxybenzyl)‐amino acids: Useful intermediates in peptide synthesis , 1995, Journal of peptide science : an official publication of the European Peptide Society.
[23] G. Glenner. Alzheimer's disease: Its proteins and genes , 1988, Cell.